Bezafibrate-Induced Changes over Time in the Expression of Uncoupling Protein (UCP) mRNA in the Tissues: A Study in Spontaneously Type 2 Diabetic Rats with Visceral Obesity

  • Mori Yutaka
    Department of Internal Medicine, National Hospital Organization, Utsunomiya National Hospital
  • Tokutate Yoshiki
    Department of Discovery Research I, Kissei Pharmaceutical Co., Ltd.
  • Oana Fumiki
    Department of Discovery Research I, Kissei Pharmaceutical Co., Ltd.
  • Matsuzawa Akane
    Department of Discovery Research I, Kissei Pharmaceutical Co., Ltd.
  • Akahane Satoshi
    Department of Discovery Research I, Kissei Pharmaceutical Co., Ltd.
  • Tajima Naoko
    Division of Diabetes and Endocrinology, Department of Internal Medicine,The Jikei University School of Medicine

この論文をさがす

抄録

The effect of short-term bezafibrate (BF) administration over time on the expression of UCP mRNA in the tissues was examined in Otsuka Long Evans Tokushima Fatty (OLETF) rats. Eight-week-old rats were divided into a high-dose (100 mg/kg) BF group (n = 15), a low-dose (10 mg/kg) BF group (n = 15) and a control group (n = 15), and followed for 14 days. Feed intake by the high-dose BF group increased significantly between days 10 and 14 of administration. Triglyceride, free fatty acid, and T4 levels decreased significantly in a dose-dependent manner in the high-dose BF group. Leptin and insulin levels significantly decreased on days 3 and 7. Throughout the study period, liver UCP2 mRNA increased in the high-dose BF group. On day 3 of BF administration, the levels of UCP2 mRNA expression in the skeletal muscles as well as UCP3 mRNA expression in the WAT were significantly increased in the high-dose BF group. PPAR-α mRNA significantly increased in the liver on day 3 of BF administration. We thus conclude that the PPAR-α-mediated effects of BF on the expression of liver UCP2 may be one of the factors that helped to decrease insulin levels.

収録刊行物

被引用文献 (6)*注記

もっと見る

参考文献 (34)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ